U.S. Hospitality Stock News

Investors may be wondering whether Autoliv stock now reflects its underlying value, or if the recent attention has left some mispricing on the table. The share price recently closed at US$121.25, with returns of 7.0% over 7 days, 15.2% over 30 days, 33.2% over 1 year, 49.8% over 3 years, 44.3% over 5 years and a small year to date loss of 0.7%. Recent coverage has focused on Autoliv as a key player in vehicle safety systems. This helps frame how investors are thinking about its earnings...

Match Group (MTCH) opened 2026 with Q1 revenue of US$863.9 million and basic EPS of US$0.71, setting the tone for how the business is entering the new year. The company has seen quarterly revenue move from US$831.2 million and EPS of US$0.47 in Q1 2025 through a series of higher and lower prints over 2025 to the latest Q1 2026 figures, giving investors a fuller view of how the top and bottom lines have tracked over the last five reported quarters. With trailing 12 month EPS at US$2.78 and net...

Wondering whether StoneX Group stock still offers value after its strong run, or if you might be late to the party? This article breaks down what the current price could mean for you. At a recent close of US$106.39, the stock shows returns of 2.6% over 7 days, 24.3% over 30 days, 63.9% year to date and 69.5% over 1 year, with a very large 5 year return of 436.3%. Recent news coverage has focused on StoneX Group's role as a global financial services company and its position in capital...

Seaboard's Q1 2026 Earnings Snapshot Seaboard (SEB) opened 2026 with Q1 total revenue of US$2.4b, basic EPS of US$124.24 and net income of US$119m, setting a fresh reference point against last year’s sharp earnings rebound. Over recent quarters the company has seen quarterly revenue move from US$2.316b in Q1 2025 to around the US$2.4b range in Q1 2026. Basic EPS shifted from US$32.95 to US$124.24. Trailing twelve month EPS reached US$606.79 alongside net income of US$583m on US$9.83b of...

Rayonier Advanced Materials (RYAM) opened 2026 with Q1 revenue of US$319 million and a basic EPS loss of US$1.21, alongside trailing 12 month revenue of about US$1.4 billion and a basic EPS loss of US$7.08. Over recent quarters the company has seen revenue move from US$422.5 million in Q4 2024 to US$355.9 million in Q1 2025, US$340.0 million in Q2 2025, US$352.8 million in Q3 2025, US$417.5 million in Q4 2025 and now US$319 million in Q1 2026, while quarterly basic EPS losses have ranged...

Devon Energy (DVN) opened 2026 with Q1 revenue of US$4.3b and basic EPS of US$0.19 on net income of US$120m, setting a cautious tone for the new year. Over the past few quarters, the company has seen revenue move between US$3.8b and US$4.3b, while quarterly EPS has ranged from about US$0.77 to US$1.42. This has contributed to trailing twelve month EPS of US$3.63 on revenue of US$16.0b. Investors are therefore likely to focus on how much of that top line converts into profit as margins adjust...

Grab Holdings (NasdaqGS:GRAB) opened 2026 with Q1 revenue of US$955 million and basic EPS of US$0.03, setting a clear marker for how its ride hailing and delivery platform is currently translating scale into per share earnings. The company has seen quarterly revenue move from US$773 million in Q1 2025 to US$955 million in Q1 2026, while basic EPS has shifted from US$0.01 to US$0.03 over the same period. Trailing twelve month EPS now sits at US$0.09 on revenue of US$3.6 billion, giving...

Bioventus (BVS) opened 2026 with Q1 revenue of US$132.1 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$576.3 million and basic EPS of US$0.43 that reflect a period of positive net income. Over recent quarters the company has seen revenue range from US$123.9 million to US$157.9 million, while basic EPS moved from a loss of US$0.04 in early 2025 to US$0.22 in Q4 2025 and US$0.05 in the latest quarter, setting up a narrative that now hinges on how durable these...

Q1 2026 headline results and setup Corteva (CTVA) opened 2026 with Q1 revenue of US$4.9 billion and basic EPS of US$1.07, with trailing twelve month net income of US$1.25 billion giving investors a fuller view of the current earnings run rate. The company reported quarterly revenue of US$4.42 billion in Q1 2025 and US$4.91 billion in Q1 2026, while basic EPS moved from US$0.97 to US$1.07 over the same period as trailing net profit margins held close to 7%. With earnings growth forecasts...

Solventum (SOLV) opened Q1 2026 with revenue of US$2.0 billion and basic EPS of US$0.07, putting fresh numbers on the table for investors focused on how its earnings profile is evolving. Over the past few reporting periods, revenue has moved between US$2.1 billion in Q1 2025 and US$2.0 billion in Q1 2026, while basic EPS shifted from US$0.79 in Q1 2025 to US$0.07 in the latest quarter, with the trailing twelve months showing revenue of US$8.3 billion and basic EPS of US$8.22. This mix of...

Standard BioTools (LAB) has kicked off Q1 2026 with revenue of about US$21.1 million and a basic EPS loss of roughly US$0.04. This sets a cautious tone around how much of that top line is flowing through to the bottom line. The company has seen quarterly revenue move between roughly US$19.6 million and US$24.8 million since Q4 2024, while basic EPS has ranged from a loss of about US$0.08 to a profit of roughly US$0.04 over the same period. This underscores how sensitive margins have been to...

Tempus AI (TEM) opened Q1 2026 with revenue of US$348.1 million and a basic EPS loss of US$0.70, while trailing 12 month figures show US$1.4 billion in revenue and a basic EPS loss of US$1.72. This keeps the focus firmly on scaling rather than profitability. Over recent quarters the company has seen revenue move from US$255.7 million in Q1 2025 to US$348.1 million in Q1 2026, with basic EPS losses ranging between US$0.25 and US$0.70 per quarter across that period. For you as an investor, this...

CRISPR Therapeutics (NasdaqGM:CRSP) has expanded its lead CAR-T program, zugo-cel, into new autoimmune disease indications. The company advanced multiple in vivo liver-directed gene editing and siRNA programs into clinical development. CASGEVY, its gene-editing therapy, continues to see commercial traction, and a recent regulatory filing aims to extend its label to younger pediatric patients. A major convertible notes offering has strengthened the balance sheet and is funding a broader...

Intapp (NasdaqGS:INTA) has reported Q3 2026 revenue of US$146.0 million with a basic EPS loss of US$0.20, alongside net income excluding extra items of a US$15.5 million loss. The company has seen quarterly revenue progress from US$121.2 million in Q2 2025 to US$129.1 million in Q3 2025 and US$146.0 million in Q3 2026. Over the same periods, basic EPS moved from a US$0.13 loss to a US$0.04 loss and then a US$0.20 loss, setting up this quarter as another test of how quickly margins can move...

Bowman Consulting Group (BWMN) opened Q1 2026 with revenue of US$126.5 million and a basic EPS loss of US$0.22, alongside trailing twelve month EPS of US$0.62 on US$503.6 million of revenue. Over the past year, the company has seen revenue move from US$444.6 million to US$503.6 million on a trailing basis, while EPS shifted from US$0.16 to US$0.62, giving investors a clear view of how the top line and per share earnings have tracked together. Taken together with a trailing net margin that now...

Ferroglobe (NasdaqCM:GSM) opened 2026 with Q1 revenue of US$347.7 million and a basic EPS loss of US$0.04, alongside a trailing 12 month net loss of US$111.3 million on revenue of US$1.4 billion. Over recent quarters the company has seen revenue move between US$307.2 million and US$386.9 million, while quarterly basic EPS has ranged from a loss of US$0.04 to a loss of US$0.43 as profitability remained under pressure and margins stayed in the red. See our full analysis for Ferroglobe. With the...

BeOne Medicines (ONC) opened 2026 with Q1 revenue of US$1.5b and basic EPS of US$2.05, alongside net income of US$227.4 million. This sets a clear marker for how the business is currently converting its top line into earnings. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q1 2026, while basic EPS shifted from essentially flat at US$0.01 to US$2.05. This gives investors a straightforward read on how profitability is tracking against the...

Hackett Group (HCKT) has opened Q1 2026 with total revenue of US$67.8 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$292.5 million and EPS of US$0.53. These figures sit against a net profit margin of 4.8% versus 7.8% a year earlier. Over recent quarters the company has seen quarterly revenue move from US$76.2 million in Q1 2025 to US$77.6 million in Q2 2025, US$72.2 million in Q3 2025 and US$74.8 million in Q4 2025, before landing at US$67.8 million in Q1...

UWM Holdings (UWMC) opened 2026 with Q1 revenue of US$752.9 million and basic EPS of US$0.09, alongside trailing twelve month revenue of US$4.0 billion and basic EPS of US$0.27 that reflect the company’s move into profitability over the past year. The company has seen quarterly revenue range from US$613.4 million in Q1 2025 to US$1.0 billion in Q4 2025, with EPS swinging from a loss of US$0.08 in Q1 2025 to a profit of US$0.11 in Q2 2025 before settling at US$0.09 this quarter. This sets up a...

Lumentum Holdings (LITE) opened Q3 2026 with revenue of US$808.4 million and basic EPS of US$1.99, supported by net income of US$142.5 million. The company has seen revenue move from US$402.2 million in Q2 2025 to US$808.4 million in Q3 2026, while basic EPS shifted from a loss of US$0.88 to a gain of US$1.99. Trailing twelve month EPS stands at US$6.21 on revenue of US$2.5 billion. This combination of profitability and revenue scale puts the focus firmly on margins as results season...

Wondering if Bath & Body Works at around US$19.20 is a bargain or a value trap? This article focuses squarely on what the current price may be implying about the stock. The stock has risen 4.7% over the last week and 6.0% over the last month, yet year to date it shows a 7.4% decline and the 1 year return stands at 34.8% lower. This pattern may catch the eye of value focused investors. Recent coverage around specialty retail and consumer discretionary spending has put companies like Bath &...

Lineage (LINE) opened Q1 2026 with revenue of US$1.3 billion and a basic EPS loss of US$0.20. On a trailing 12 month basis, revenue stood at US$5.4 billion and basic EPS was a loss of US$0.63, alongside trailing 12 month revenue growth of 4.6% a year versus 11.3% for the broader US market. Over recent quarters, revenue has moved in a narrow band between US$1.29 billion and US$1.38 billion, while quarterly basic EPS has ranged from a loss of US$0.44 to a small profit of roughly US$0.03. This...

Some investors may be considering whether Douglas Dynamics at around US$45.42 is still offering value after a strong run, or whether much of the opportunity is already reflected in the current share price. The stock has recorded returns of 2.8% over 7 days, 8.1% over 30 days, 37.7% year to date and 83.6% over 1 year. This puts recent price action front and center for anyone weighing the balance between potential and risk. Recent coverage has highlighted Douglas Dynamics as a Machinery sector...

Uber Technologies (UBER) opened 2026 with Q1 revenue of US$13.2b and basic EPS of US$0.13, setting the tone for how investors assess profit quality after a year in which trailing twelve month EPS sat at US$4.12. The company reported quarterly revenue increasing from US$11.5b in Q1 2025 to US$13.2b in Q1 2026, while basic EPS moved from US$0.85 to US$0.13 over the same period, against a trailing net income base of US$8.5b. With margins firmly in focus after the past year's compression, this...